CLOSE

Specials

  • March
  • June
  • September
  • Bioanalytical Services
  • Life Science Analytics
  • Life Science Compliance
  • Bioanalytical Services APAC
  • APAC
  • Europe

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects...

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial...

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech...

Cyberattacks in Hospitals

Cyberattacks in Hospitals

How AI Can Enhance the Prediction of Immunotherapy

How AI Can Enhance the Prediction of...

How Technology is Reshaping Immunotherapy

How Technology is Reshaping...

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects...

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial...

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech...

Cyberattacks in Hospitals

Cyberattacks in Hospitals

How AI Can Enhance the Prediction of Immunotherapy

How AI Can Enhance the Prediction of...

How Technology is Reshaping Immunotherapy

How Technology is Reshaping...

Obstacles to AI in Life Sciences: The Imperative of Good Data Hygiene

By Life Sciences Review | Tuesday, December 15, 2020
Tweet

Reasonably, as AI operates on large sets of data, the accessibility of clean data at scale becomes a fundamental precursor to creating a suitable environment for the growth of AI-based solutions. It is the essence of the process.


FREMONT, CA: With many rough estimates being deliberated around artificial intelligence’s potential to alter healthcare for the better radically, it is easy to lose view of the fact that manifestation of that vision will be far from easy. Admittedly, the task at hand can seem quite tricky. Most pharma companies’ current IT infrastructures are based on legacy systems that were just not designed with Artificial Intelligence (AI) in mind: their data, if stored at all, is usually kept in clumsy free form and their systems lack interoperability.


Reasonably, as AI operates on large sets of data, the accessibility of clean data at scale becomes a fundamental precursor to creating a suitable environment for the growth of AI-based solutions. It is the essence of the process. Without this vital underlying infrastructure of big data, the potential of AI technology will surely fall short. The visceral reality is AI approaches can only be as good as the data applied to them. 


See Also: Top Pharma and Life Sciences Tech Solution Companies


If one puts junk in, they can only expect to get the junk out.


The first thing involved is to learn the importance of having outstanding data actually to base the machine learning on. One has to spend a lot of time and efforts just cleaning the data sets as a prerequisite to being able to run the algorithm as it might take years to clean the datasets. People tend to undervalue only how little clean data is available, and how hard it is to clean and link it all up.


The current abundance of poor data hygiene will probably mean that the practical introduction of AI-based healthcare will be uneven and unstable, at least in the preliminary stages. There are already some indicators of this happening. Healthcare, being a significantly regulated industry, is explicitly a data-rich, but that does not necessarily means that the statistics is balanced. For instance, in Asia to reap the benefits of AI, there is an urgent necessity to increase the availability of Asian-specific data. At present, existing genetics and clinical trial databases are mostly made up of Caucasian data, which means entire geographic regions and ethnic groupings risk being left behind as the technology takes off.


Weekly Brief

loading
Towards a New World Order
> <
  • Other 2021

    Top Vendors

    Current Issue
  • Other 2020

    Top Vendors

    Current Issue

Read Also

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of ADCs

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Importance of Biomarkers in Drug Development

Importance of Biomarkers in Drug Development
Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects of Immunotherapy

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech Sector

Why Partner with Bioanalysis Experts?

Why Partner with Bioanalysis Experts?
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/obstacles-to-ai-in-life-sciences-the-imperative-of-good-data-hygiene-nwid-208.html